Why the study?
CMR is useful for establishing the underlying aetiology of MINOCA during the acute phase, but its role in follow-up is less well established.
Does follow-up CMR reveal additional pathology in patients with MINOCA/Takotsubo syndrome?
Does follow-up CMR reveal additional pathology in patients with MINOCA/Takotsubo syndrome?
Follow-up CMR in patients with MINOCA/Takotsubo syndrome may reveal additional actionable pathology such as ischemic injury not apparent during the acute phase.
No takes yet. Share an insight, caveat, or question.
Follow-up CMR may detect occult infarction in presumed TTS/MINOCA prompting therapy change; leaves open routine serial imaging value.
Pradhan et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: